Related Experiment Video
Updated: Jun 18, 2026

07:18
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
Engineering potent TILs from an immune-excluded tumor: Insights from chondrosarcoma
Rusul Al-Marayaty1, Seth M Pollack2
1MedStar Washington Hospital Center Washington, Washington, DC, USA.
Molecular Therapy. Oncology
|June 17, 2026
Summary
No abstract available in PubMed .

